Antiviral combination comprising nucleoside analogs
US5122517A · kind A · utility
40Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1990 |
| Grant date | Jun 16, 1992 |
| Priority date | — |
| Expiry date | Nov 13, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antiviral and antitumor compositions are disclosed comprising a mixture of AZT, ribavirin, d4T or CS-87 with a compound of general formula: ##STR1## wherein Z is H, OH or NH.sub.2, Y is CH, and X is selected from the group consisting of H, N(R).sub.2, SR, OR or halogen, wherein R is H, lower(C.sub.1 -C.sub.4)alkyl, aryl or mixtures thereof, and the pharmaceutically-acceptable derivatives thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.